What is Concentrics Research?
As an IQVIA business, Concentrics Research operates as a specialized clinical research organization with a distinct focus on Phase II-IV trials and consumer healthcare research. The company distinguishes itself by integrating a clinical division with a regulated healthcare market research arm, supported by a dedicated research site for iterative testing. With nearly three decades of industry expertise, the firm provides bespoke research solutions designed to meet the complex regulatory and commercialization requirements of modern drug and medical device developers. Their methodology emphasizes the intersection of rigorous scientific standards and creative, efficient problem-solving, which is essential for navigating the complexities of late-stage clinical development.
The company's unique value proposition lies in its ability to bridge the gap between early-stage clinical validation and final market entry. By offering a comprehensive suite of services that cater to both pharmaceutical and consumer health clients, Concentrics Research maintains a versatile portfolio that is resilient to market fluctuations. Their deep integration with IQVIA further enhances their data-driven approach, allowing for more precise patient recruitment and data analysis, which are critical components for successful late-stage trial outcomes.
How much funding has Concentrics Research raised?
Concentrics Research has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Concentrics Research
PPP
Public-Private Partnership
What's next for Concentrics Research?
Looking ahead, the recent capital injection is expected to catalyze the expansion of Concentrics Research's service offerings and technological infrastructure. The firm is likely to prioritize the scaling of its clinical trial management systems and the enhancement of its regulatory market research capabilities to better serve a global client base. As the demand for efficient, high-quality clinical data continues to rise, the company is strategically positioned to leverage its existing expertise to capture a larger share of the late-stage research market. Future growth will likely focus on optimizing trial timelines and improving the commercialization success rates for its partners, thereby reinforcing its status as a leader in the clinical research services domain.
See full Concentrics Research company page
